Victory Capital Management
ARRY

Victory Capital Management’s Array Biopharma Inc ARRY Stock Holding History

Victory Capital Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,930
Closed -$71K – 1879
2019
Q1 		$71K Hold
2,930
– – ﹤0.01% 1682
2018
Q4 		$42K Sell
2,930
-558
-16% -$8.46K ﹤0.01% 1708
2018
Q3 		$53K Buy
3,488
+458
+15% +$7.02K ﹤0.01% 1724
2018
Q2 		$51K Sell
3,030
-62,010
-95% -$986K ﹤0.01% 1758
2018
Q1 		$1.06M Buy
65,040
+62,010
+2,047% +$993K ﹤0.01% 1229
2017
Q4 		$39K Hold
3,030
– – ﹤0.01% 1762
2017
Q3 		$37K Sell
3,030
-107,968
-97% -$1M ﹤0.01% 1756
2017
Q2 		$929K Sell
110,998
-1,860
-2% -$15.2K ﹤0.01% 1203
2017
Q1 		$1.01M Buy
+112,858
New +$1.2M ﹤0.01% 1170

Other funds holding ARRY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Victory Capital Management's ARRY Position: Q2 2019 in Review

Victory Capital Management sold out of Array Biopharma Inc (ARRY) in Q2 2019, closing a stake of 2,930 shares — an estimated $71K sold.

Victory Capital Management first reported a position in ARRY in Q1 2017 and held it in 9 quarters. The position peaked at $1.06M in Q1 2018. 319 funds tracked by Wall St. Rank hold ARRY as of Q2 2019.

  • Victory Capital Management reported no remaining Array Biopharma Inc position as of Q2 2019 after selling out during the quarter.
  • Victory Capital Management sold 2,930 Array Biopharma Inc shares in Q2 2019, an estimated $71K.
  • Victory Capital Management first reported a position in Array Biopharma Inc in Q1 2017 and held it in 9 quarters.
  • Victory Capital Management's Array Biopharma Inc position peaked at $1.06M in Q1 2018.
  • 319 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q2 2019.

Based on Victory Capital Management's 13F filing for Q2 2019, filed 15 Aug 2019.